Bristol Myers restarts radiopharmaceutical Phase 3 trial, but delays readout by one year

Bris­tol My­ers Squibb has re­sumed re­cruit­ment for its lead ra­dio­phar­ma­ceu­ti­cal tri­al af­ter an iso­tope short­age forced a pause ear­li­er this year, chief med­ical of­fi­cer Samit …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.